Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hydroxyurea × 90 days × Clear all

Phase

Phase 1 5 Phase 2 3 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

Letrozole 6 Specimen Handling 5 Rituximab 5 Dexamethasone 5 Tobacco Use Cessation Devices 4 Tamoxifen 4 Prednisone 4 Cisplatin 4 Carboplatin 4 Bevacizumab 4 Anastrozole 4 ribociclib 3 pirtobrutinib 3 pembrolizumab 3 exemestane 3 atezolizumab 3 Vincristine 3 Trastuzumab 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Injections 3 Everolimus 3 Doxorubicin 3 trametinib 2 relatlimab 2 obinutuzumab 2 nilotinib 2 gadolinium ethoxybenzyl DTPA 2 enzalutamide 2 enfortumab vedotin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05853458 2026-04-07

HU-F-AIM

Novartis

Phase 4 Terminated

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡